| abstract |
Antibodies and antigen-binding fragments thereof such as those that recognize or bind to human papilloma virus (HPV) 16, including binding molecules such as TCR or antigen binding fragments thereof, and HPV16 E6 and HPV16 E7 are provided. Also provided are an engineered cell containing the binding molecule, a composition containing the binding molecule or engineered cells, and a method of treatment such as administering the binding molecule, engineered cell or composition. |